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Abstract
Systematic reviews aim to summarize all the available evidence relevant to a par-
ticular research question. If appropriate, the data from identified studies are quanti-
tatively combined in a meta-analysis. Often only few studies regarding a particular
research question exist. In these settings the estimation of the between-study het-
erogeneity is challenging. Furthermore, the assessment of publication bias is difficult
as standard methods such as visual inspection or formal hypothesis tests in funnel
plots do not provide adequate guidance. Previously, Henmi and Copas (Statistics in
Medicine 2010, 29: 2969–2983) proposed a confidence interval for the overall effect
in random-effects meta-analysis that is robust to publication bias to some extent.
As is evident from their simulations, the confidence intervals have improved coverage
compared with standard methods. To our knowledge, the properties of their method
has never been assessed for meta-analyses including fewer than five studies. In this
manuscript, we propose a variation of the method by Henmi and Copas employing
an improved estimator of the between-study heterogeneity, in particular when dealing
with few studies only. In a simulation study, the proposed method is compared to sev-
eral competitors. Overall, we found that our method outperforms the others in terms
of coverage probabilities. In particular, an improvement compared with the proposal
by Henmi and Copas is demonstrated. The work is motivated and illustrated by a
systematic review and meta-analysis in paediatric immunosuppression following liver
transplantations.
Keywords: Meta-analysis; publication bias; between-trial heterogeneity; confidence
interval; coverage probability
1 INTRODUCTION
Systematic reviews aim to summarize all the available evidence relevant to a particular
research question. If appropriate, the data from identified studies are quantitatively com-
bined in a meta-analysis. If the true effect is the same in all studies to be combined
in a meta-analysis, then the so-called common-effect or fixed-effect model is appropriate.
In practical applications this assumption often appears to be too strict as some level of
between-trial heterogeneity in the effects is suspected. Then the random-effects model is
∗correspondence to: Tim Friede, Department of Medical Statistics, University Medical Center
Go¨ttingen, Germany; email: tim.friede@med.uni-goettingen.de
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applied which treats the latent study-specific effects as random from an assumed distri-
bution, often a normal distribution. Inference regarding the overall effect in the standard
model relies on normality assumptions which apply if the number of trials and the trials
themselves are sufficiently large. A number of estimators for the between-trial heterogene-
ity have been proposed [1]; among them the standard approach by DerSimonian and Laird
[2].
Recently the topic of meta-analysis of few studies, say 2 - 5, got more attention, since
this case is very common in practice. With few studies, however, confidence intervals of the
overall effect based on normal quantiles tend to be too short as they ignore the uncertainty
in estimating the between-trial heterogeneity. As remedies, methods based on t-quantiles
have been proposed [5, 6, 7, 8]. With few studies only, however, they are often conservative
and so long that they are uninformative [9]. Also various likelihood-based methods have
recently been assessed in the specific situation of few studies and not found to be a solution
to the problem [10]. Between-trial heterogeneity estimates mentioned above often result in
zero [4], with the notable exception of the method proposed by Chung et al [3]. Chung et al
suggested the so-called Bayes modal (BM) estimator, which uses in a Bayesian framework a
weakly informative prior for the between-trial heterogeneity to avoid zero estimates of the
heterogeneity. Furthermore, a fully Bayesian approach to random-effects meta-analysis
with weakly informative priors for the between-trial heterogeneity parameter has some
advantages in this situation, since zero estimates are avoided as with the BM estimator
and in addtition the uncertainty in estimating the heterogeneity is accounted for [4, 11].
Of course the Bayesian credible intervals would not necessarily have frequentist properties.
Evaluating the operating characteristics in extensive simulation studies, it was found that
the frequentist coverage probabilities are often above the nominal level with conservative
choices of the prior for the between-trial heterogeneity [4, 11]. Bender et al[12] recently
provided an overview on the topic of meta-analyses with few studies.
In systematic reviews, relevant evidence is identified through systematic searches of
literature databases. If all relevant studies would be published, this would be sufficient.
However, this is not always the case. The problem was first described as the ’file drawer
problem’ [13]. Today various types of reporting biases are carefully distinguished including
publication bias, time lag bias, citation bias and outcome reporting bias to name but a
few. Studies might not be published at all for various reasons or only with a certain delay
or in journals or languages that are more difficult to access (see e.g. Table 7.2.a in [14]).
In the following we focus here on the aspect of publication bias. Prospective registration
of clinical trials is one way to tackle this problem. It has become standard practice to
search not only at least two electronic databases of the literature but also to search at least
one registry for clinical studies such as clinicaltrials.gov. The idea would be to include
unpublished studies in systematic reviews. However, access to the unpublished results is
often challenging as it requires the cooperation of investigators, sponsors etc.
A number of methods have been proposed over the years to deal with publication bias
[15]. A popular way to interrogate data for publication bias is the visualization in form
of a so-called funnel plot. In this scatter plot, each study contributes an estimate of an
effect measure and its estimated standard error. The former is plotted on the x-axis, the
latter on the y-axis. If no publication bias is present, we would expect the plot to be
symmetric to the vertical line running through the average effect. Any absence of this
symmetry might be interpreted as a signal that some form of reporting bias might be
present. As this can be difficult to judge, formal hypothesis tests have been proposed
(see e.g. [16]). The problem with the visual inspection as well as with the formal tests
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is that they become more powerful with larger number of studies, but are less sensitive
with few studies only. In the context of funnel plots, trim-and-fill methods have been
proposed to correct the overall effect for potential publication bias [17]. Following an
alternative approach, several sensitivity analysis methods have been suggested based on
selection functions describing the selective publication process [18, 19, 20]. For instance,
Copas and Jackson [19] investigated the maximum bias over all possible selection functions
which satisfy the (fairly weak) condition that studies with smaller standard errors are at
least as likely to be selected than studies with larger standard errors. Building on their
work, Henmi et al [20] developed sensitivity analyses that, in contrast to the proposal by
Copas and Jackson [19], account for uncertainty in estimation. Again, the methods are
not designed for the setting of few studies only.
Our work is motivated by a systematic review and meta-analysis of controlled clinical
trials assessing efficacy and safety of Interleukin-2 receptor antagonists (IL-2RA) in chil-
dren having undergone liver transplantations [21], a rare surgical procedure in children.
In total only six relevant studies were identified with little standardization with regard
to the design of the studies implying some level of heterogeneity. Although the authors
carefully checked for publication bias using standard techniques, it cannot be excluded
that in particular some smaller studies were not published if they resulted in inconclusive
treatment effects.
In contrast to the approaches to publication bias described above, Henmi and Copas
[22] proposed a method for random-effects meta-analysis that is robust to the selection of
studies. They modified the DerSimonian-Laird (DL) confidence interval ([2], (10) in [22])
by replacing the random-effect estimator by the fixed-effect estimator of the overall effect
and by replacing the normal quantiles by more accurate ones. The latter depends on the
between-trial heterogeneity. The DL estimator is used in the computation of the quantiles.
Therefore, with few studies this approach may not work well. In this paper, we propose
a modification of the Henmi-Copas method by replacing the estimator of the between-
study heterogeneity in the computation of the quantiles by the one developed by Chung
et al [3]. The properties of the new approach are assessed and compared to alternative
methods including the Henmi-Copas approach and a proposal by Doi et al [23] in Monte
Carlo simulation studies considering in particular the case of few studies with and without
publication bias. Our method is not conditional on having detected publication bias, e.g.
in a funnel plot, since this would be very difficult with only few studies included in the
meta-analysis. But it is robust to the selection of studies even with few studies as we will
see below.
The manuscript is organized as follows. In the next section the new confidence interval
for the overall effect is developed starting by introducing notation and reviewing the
method of Henmi and Copas [22]. The simulation study assessing the properties of the
new confidence interval in comparison to existing methods is presented in Section 3. In
Section 4 the proposed method is applied to the motivating example. We close with a
brief discussion of our findings and their limitations.
2 METHODS
Adopting the notation by Henmi and Copas [22], the true effect of an individual study i
out of n independent studies is denoted by θi. Estimates yi of the effects θi are observed
with stand errors σi. Here we consider the normal-normal hierarchical model (NNHM),
which is the standard model for random-effects meta-analysis. In the NNHM, it is assumed
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that the θi are from a normal distribution with expectation θ and variance τ
2, i.e.
θi|θ, τ ∼ N(θ, τ2), i = 1, . . . , n. (1)
Furthermore, the effect estimators Yi follow (at least approximately) a normal distribution
with expectation θi and variance σ
2
i , i.e.
Yi|θi ∼ N(θi, σ2i ), i = 1, . . . , n. (2)
From Equations (1) and (2) they follow the marginal model
Yi|θ, τ ∼ N(θ, σ2i + τ2), i = 1, . . . , n. (3)
If the between-trial heterogeneity τ2 is 0, then the random-effects model reduces to the
so-called fixed-effect or common-effect model.
The focus of our study is inference regarding θ, the overall effect. A standard method to
construct an estimator and a (1−α) confidence interval for θ was proposed by DerSimonian
and Laird [2] (DL). In short, the DL estimator of θ is given by
θˆR =
∑
wˆiYi/
∑
wˆi , (4)
where wˆi = 1/(σ
2
i + τˆ
2
DL). Here, the DL estimator τˆ
2
DL of the between-study heterogeneity
τ2 is given by
τˆ2DL = max
{
0,
Q− (n− 1)∑
wi −
∑
w2i /
∑
wi
}
. (5)
The weights wi are the fixed effect weights (with τ
2 = 0), which are wi = 1/σ
2
i . Further-
more, Q is the so-called Q-statistic defined by
Q =
∑
wi(Yi − θˆF )2 , (6)
where θˆF is the fixed (or common) effect estimator of the overall effect with
θˆF =
∑
wiYi/
∑
wi . (7)
If the estimator τˆ2DL is assumed to be a fixed constant as the true value of τ
2, then it holds
that
Z =
θˆR − θ
1/
√∑
wˆi
∼ N(0, 1) . (8)
This results in the DerSimonian-Laird (1 − α)% confidence interval (DL) for θ, which is
given by (
θˆR − z(1−α)/2
1√∑
wˆi
, θˆR + z(1−α)/2
1√∑
wˆi
)
, (9)
where zγ is the γ quantile of the standard normal distribution. The assumption that
the estimate τˆ2DL is the true value of τ
2 might be reasonable when the between-study
heterogeneity can be estimated with high precision, i.e. when the number of studies
included in the meta-analysis is large. In medical applications, however, this is frequently
not the case. As noted by several authors, the application of the DL approach in meta-
analyses with small to moderate numbers of studies results in coverage probabilities below
the nominal level 1− α [4].
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Henmi and Copas [22] tackled the two problems that (a) the distribution of the pivot
statistic is quite different from the standard normal distribution when the number of
studies n is small, and (b) the estimators of θ are biased due to selective publication of
smaller studies with less favourable results (publication bias). With respect to the latter
they note that the common (or fixed) effect estimator θˆF is more robust to publication
bias than the random-effects estimator θˆR simply because smaller studies, which are less
likely to be published when their outcome is not favourable, have a smaller weight in the
construction of θˆF than in θˆR. To address the problem of the normal approximation they
derive the distribution of the pivot statistic based on the fixed effect estimator under the
random-effects model. More specifically, the variance of θˆF is
V (τ2) =
τ2
∑
w2i +
∑
wi
(
∑
wi)2
. (10)
The variance V (τ2) can be estimated by plugging in τˆ2DL for τ
2. We denote this estimator
of V (τ2) by
V (τˆ2DL) =
τˆ2DL
∑
wˆ2i +
∑
wˆi
(
∑
wˆi)2
. (11)
Recall that the weights wˆi also depend on τˆ
2
DL. Hence, the pivot statistic U is given by
U =
θˆF − θ√
V (τˆ2DL)
. (12)
The point in the derivation of the distribution of U by Henmi and Copas [22] is to take
into account the random variation of τˆ2DL in addition to θˆF as follows.
The distribution function of U can be written as
P (U ≤ u) =


1−
∫
∞
u
P
(
Q ≤ f−1
(
r
u
)∣∣∣∣R = r
)
pR(r)dr (if u ≥ 0)∫ u
−∞
P
(
Q ≤ f−1
(
r
u
)∣∣∣∣R = r
)
pR(r)dr (if u < 0)
, (13)
where the random variable R and the function f are defined by
R =
∑
wi(Yi − θ)√∑
wi
and f(Q) =
√∑
w2i {Q− (n− 1)}
(
∑
wi)2 −
∑
w2i
+ 1, (14)
respectively. The function pR(r) is the probability density function of R, which is the nor-
mal density with mean zero and variance 1+τ2(
∑
w2i /
∑
wi). The conditional distribution
of Q given R, which is necessary to calculate the integral in (13), is a little complicated,
but it is well approximated by the gamma distribution whose mean and variance coincide
with the exact conditional mean M(R) and variance V (R) of Q given R, respectively (see
[22] and its Appendix A for the explicit formulas ofM(R) and V (R) and their derivation).
Since both of the conditional meanM(R) and variance V (R) depend on the unknown true
value of τ2 as does the variance of R, Henmi and Copas [22] proposed the use of the DL
estimator τˆ2DL for τ
2 again to approximate these quantities. Under this setting, the (ap-
proximate) γ quantile uγ of U can be obtained by means of numerical integration and
optimization (see Appendix B in [22] for an implementation in R) and hence a (1 − α)
confidence interval for θ is given by
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(
θˆF − uα/2
√
V (τˆ2DL), θˆF + uα/2
√
V (τˆ2DL)
)
. (15)
In simulation studies, Henmi and Copas [22] could show that their approach improves
coverage probabilities as compared to standard procedures including the DL approach.
With only few studies included in the meta-analysis, however, the performance is not
satisfying. The poor performance of the method in this particular situation is caused (at
least partly) by the use of the DL estimator τˆ2DL in the computation of the quantiles of the
pivot statistic U as above, since τˆ2DL results frequently in zero estimates with few studies
although the between-trial heterogeneity is positive, τ2 > 0.
The use of weakly informative priors for the between-study heterogeneity to avoid zero
estimates has been advocated for some time, whereas an uninformative, e.g. improper
uniform, prior is used for the effect θ [25, 26]. A number of suggestions have been made
on the choice of such weakly informative priors for τ including half-t [26] and half-normal
distributions [4]. Here we follow Chung et al [3] who proposed to use a gamma distribution
with shape η and rate λ as a prior for τ , specifically p(τ) = λητη−1e−λτ/Γ(η) with gamma
function Γ(η). This choice means that the logarithm of the posterior of θ and τ is equal to
the log likelihood plus a term depending only on τ but not θ. Rather than using the mean
or median of the posterior, Chung et al [3] consider the mode, which can be computed
by numerical optimization. This estimator of τ is referred to as the Bayes Modal (BM)
estimator τˆBM . As default, Chung et al recommend to use α = 2 and λ close to 0. The
BM estimator τˆBM can be interpreted as a penalized maximum likelihood (ML) estimator
[3].
In this paper, we propose to replace the DL estimator τˆ2DL in the computation of
the quantiles of the pivot statistic U by the BM estimator τˆ2BM . The choice of the BM
estimator is motivated by its performance in comparison to other estimators in recent
simulation studies (see e.g. Figures 2 and 3 in [4]). The resulting γ quantile is denoted by
u
(BM)
γ . The (1− α) confidence interval for θ is then given by
(
θˆF − u(BM)α/2
√
V (τˆ2DL), θˆF + u
(BM)
α/2
√
V (τˆ2DL)
)
. (16)
In summary, our idea is that we still use the DL estimator τˆ2DL in the construction of
the pivot statistic U given in (12) in the same way as Henmi and Copas [22], but we use
the BM estimator τˆ2BM in the approximate calculation for the distribution of U instead of
τˆ2DL. The reason for the use of the DL estimator τˆ
2
DL in the construction of U is that it is
easier to calculate the distribution of the pivot statistic U , taking into account the effect
of estimating τ2. However, the distribution of U depends on the unknown true value of τ2
and it is necessary to use some estimate of τ2 to approximate the distribution of U . One
possibility is to use the DL estimator τˆ2DL again, which was done in [22], but it would be
inaccurate unless the number of studies are sufficiently large. Hence, we propose the use of
the BM estimator τˆ2BM to improve the accuracy in estimating τ
2 and in approximating the
distribution of U , which we expect to lead the improvement of the coverage probabilities of
the Henmi-Copas (HC) confidence interval (15). In the next section, by simulation studies,
we show that the new confidence interval (16) actually improves the HC confidence interval
(15) in coverage probability as well as the DL confidence interval (9) in both cases with
and without publication bias, especially when the number of studies is small.
6
Table 1: Summary of the scenarios considered in the simulation study
Parameter Values
Treatment effect θ 0.5
Between-trial heterogeneity τ2 0.05, 0.15, 0.25
Number of trials included in the meta-analysis n 3, 6, 9, 12, 15
Selection model
No publication bias
Moderate publication bias β = 4, γ = 3
Severe publication bias β = 4, γ = 1.5
3 SIMULATION STUDY
In order to compare the performance of the proposed approach with previously suggested
procedures a Monte Carlo simulation study was conducted. As comparators the methods
by Henmi and Copas [22] (HC), Chung et al [3] (BM), Doi et al [23] (IVH) and DerSimo-
nian and Laird [2] (DL) were included. The first one is known to be robust to publication
bias to some extent, but its performance in meta-analyses with few studies only is un-
known. The approach by Chung et al [3] was developed for the scenario of few studies
but might not be robust to publication bias. Doi et al [23] proposed the inverse variance
heterogeneity model. As with the HC approach, the interval is centred around an esti-
mator assuming the common-effect model. Therefore, it might have attractive properties
in settings with publication bias. In contrast to the HC approach, however, it is based
on normal approximation. This approach was not included in recent method compari-
son studies [24]. The DL approach was included here as it is often considered to be the
standard approach to random-effects meta-analysis. The simulation model by Brockwell
and Gordon [27] formed the basis for our simulation study. It was used in several recent
simulation studies and therefore appeared to be a good choice. To account for publication
bias, we used the same selection function (probability that a study with an outcome y and
associated standard error σ is selected in the meta-analysis)
P (selected|y, σ) = exp
[
−β
{
Φ
(
− y
σ
)}γ]
(17)
as in [22] with the same sets of the parameters β and γ for moderate and severe publication
bias. Here, Φ is the cumulative distribution function of the standard normal distribution.
Table 1 summarizes the simulation scenarios considered. Per scenario N = 2, 000 simula-
tion replications were run.
Figure 1 presents the simulated coverage probabilities for the different confidence inter-
vals in the various scenarios. In all scenarios considered, the proposed method performs at
least as well as the HC method in terms of the coverage probability. With larger number
of studies, say n ≥ 9, and more pronounced between-trial heterogeneity, say τ2 ≥ 0.15,
the performance of both approaches is fairly similar. With smaller numbers of studies or
only low levels of heterogeneity, however, there is a clear advantage for the new proposal
as it improves the coverage probability considerably. In scenarios with few studies, n = 3
or n = 6, and only low levels of between-trial heterogeneity, τ2 = 0.05, the coverage prob-
abilities of the BM approach are slightly higher than those of the proposed method. In the
scenarios with publication bias, however, the coverage probabilities of the BM approach
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rapidly decrease well below the nominal level of 0.95 with increasing numbers of studies
included in the meta-analysis and increasing levels of between-trial heterogeneity. With-
out publication bias, the coverage of the IVH interval is similar to the coverage of the DL
interval, i.e. poor for small numbers of studies n and closer to the nominal level for larger
n. In the settings with publication bias the coverage probabilities of the IVH intervals
are generally larger than those of the DL approach, in particular with more pronounced
heterogeneity τ2 and larger numbers of studies n. However, the coverage probabilities are
below those achieved by the HC and HC-BM approaches. Overall, the coverage probabil-
ities of the proposed approach are closest to the nominal level whereas the coverages for
the DL approach are well below the nominal level for several scenarios characterized by
publication bias and small numbers of studies included in the meta-analysis.
In scenarios where different methods resulted in similar coverage probabilities close
to the nominal level it is of interest to compare the length of the intervals obtained by
these methods. Shorter intervals with the same coverage would of course be preferred.
Table 2 gives the median interval lengths of the different confidence intervals for various
levels of publication bias and heterogeneity τ2 as well as numbers of studies n included
in the meta-analysis. For instance, in the setting without publication bias and n = 3
studies the median length of our proposed confidence interval (HC-BM interval) is 1.12,
which is slightly larger than the median length of the BM intervals (1.15) although the
coverage is 0.96 just below the coverage of the BM intervals (0.97). Similarly, with n = 6
studies the median lengths of the HC-BM and BM intervals are 0.76 and 0.67, respectively.
In scenarios where the coverages of the HC and HC-BM intervals are close, the median
lengths of the intervals are similar again. In the scenarios without publication bias, where
the coverages of the DL and IVH intervals are similar, the IVH intervals tend to be longer
than the DL intervals when heterogeneity is present (i.e. τ > 0). This is expected since the
common-effect estimator employed by the IVH interval is less efficient in this situation. As
we have seen above, looking across all scenarios considered the HC-BM intervals achieve
the best coverage. However, the price for this performance of coverage is paid by somewhat
longer lengths when comparing to methods that achieve the desired coverage in particular
situations but not in others.
4 APPLICATIONTO A SYSTEMATIC REVIEW IN PAE-
DIATRIC LIVER TRANSPLANTATION
Crins et al [21] report a systematic review and meta-analysis evaluating Interleukin-2
receptor antibodies (IL-2RA) for immunosuppression in children who underwent liver
transplantation. The authors identified a total of six controlled studies including two
randomized trials. Given the heterogeneity in the designs of the studies, some between-
study heterogeneity in the treatment effects can be expected. Although Crins et al [21]
did not identify any publication bias by visual inspection of funnel plots and formal tests
for asymmetry of these plots, this provides little reassurance that indeed no publication
bias is present, since the number of studies is fairly small, which hinders the identification
of publication bias in funnel plots or formal hypothesis tests. Therefore, there is a need
for methods for random-effects meta-analyses robust to publication bias in this setting.
The endpoint acute rejections was reported in all six studies identified in the systematic
review, whereas only three also reported the outcome steroid-resistant rejections. Table
3 summarizes the findings for both outcomes. These data were previously considered by
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Friede et al [4] who applied several point estimators and confidence intervals of the overall
effect including DL and BM to these. For acute rejections, DL and BM yielded log odds
ratios (95% confidence interval) of -1.59 (-2.21, -0.96) and -1.61 (-2.35, -0.87), respectively.
The between-study heterogeneity was estimated as τˆ2DL = 0.16 and τˆ
2
BM = 0.38 with the
DL and BM methods, respectively. The fixed-effect estimate of the overall effect is -1.56
smaller than the random-effects estimates. The HC interval given by (-2.24, -0.89) is
centred around the fixed-effect estimate. The HC-BM interval proposed here is calculated
as (-2.31, -0.82) which is considerably wider than the HC interval.
For steroid-resistant rejections, DL and BM resulted in a log odds ratio (95% confi-
dence interval) of -1.21 (-2.28, -0.15) and -1.32 (-2.78, 0.14), respectively. Whereas the
DL method results in a statistically significant treatment difference, the effect is not sta-
tistically significant with the BM approach although the point estimate hints at a more
pronounced treatment effect. This is explained by the larger between-study heterogeneity
of τˆ2BM = 0.87 with the BM method which compares to τˆ
2
DL = 0.14 with the DL method.
These compare to the fixed-effect estimate of -1.17 with 95% confidence intervals of (-2.24,
-0.09) and (-2.53, 0.20) for the HC and HC-BM methods, respectively. Again, the fixed-
effect estimate is smaller than the effects obtained from random-effects meta-analyses.
Furthermore, the HC-BM confidence interval is wider than the HC interval. Here, this
wider interval means that the effect is no longer statistically significant on the usual 5%
level.
5 DISCUSSION
Meta-analyses of only a few studies are very common, but pose a number of challenges.
These include the estimation of between-trial heterogeneity as well as the assessment of
publication bias. Here we proposed a method that faces both challenges successfully. The
confidence interval of the overall effect proposed by Henmi and Copas [22] was improved
by replacing the DerSimonian-Laird estimator by the Bayes Modal estimator of Chung et
al [3] in the computation of the quantiles to construct the confidence interval. The use
of a weakly informative prior biases the Bayes Modal estimator away from zero. This
resulted in larger quantiles, in particular in situations with few studies and only small
to moderate levels of between-trial heterogeneity, which improved the coverage of the
confidence intervals.
There are a number of limitations. We focused on properties related to estimating
the overall effect and did not consider other parameters such as the heterogeneity τ2 [31].
Furthermore, we refrained form investigating other selection functions, since Henmi and
Copas state that their “experience of working with other such models suggests that the
extent of bias depends much more on the choice of selection parameters [. . . ] than it does
on the particular mathematical form of the selection function itself” [22]. Also, we did not
include other comparators such as the Knapp-Hartung-Sidik-Jonkman approach [6, 7, 8],
since extensive comparisons were included in the paper by Henmi and Copas [22] and also
in more recent simulation studies [4, 11].
The normal-normal hierarchical model considered here is a standard model for random-
effects meta-analyses. This model is very general but not without limitations since effect
estimates are modelled and not the data directly implying a two-step procedure. For
instance, considering binary outcomes and treatment effects summarized by odds ratios
Jackson et al [28] discuss six alternative generalised linear mixed models which are more
efficient one-step procedures. Modelling the data directly can have particular benefits
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when dealing with rare events; see for example Gu¨nhan et al [29] or Gronsbell et al [30].
The approach taken here to improve the coverage of confidence intervals of the overall
effect in pairwise meta-analysis might also be useful in more complex settings such as
meta-regression or network meta-analysis. The exploration of such opportunities is out of
the scope of this manuscript but subject of future research.
Highlights
What is already known
• Estimated overall effects from meta-analyses might be impacted by reporting bias
• A confidence interval for the overall effect has been proposed that is to some extent
robust to the selection of studies
What is new
• The performance of the robust confidence interval previously proposed is assessed in
meta-analyses with few studies and found not to work well in this setting
• The approach is refined resulting in improved coverage probabilities of the confidence
intervals in particular in meta-analyses with few studies
Potential impact for RSM readers outside the authors field
• The refined approach is recommend for application in meta-analyses with few studies
yielding more reliable results
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paper by Crins et al [21] and are also included in the R package bayesmeta available from
CRAN.
Acknowledgements
The authors are grateful to Professor John Copas (Warwick) for discussions during his
visit to Tokyo and Osaka in spring 2019.
ORCID
Satoshi Hattori 0000-0001-5446-2305
Tim Friede 0000-0001-5347-7441
References
[1] Veroniki AA, Jackson D, Viechtbauer W, Bender R, Bowden J, Knapp G, Kuß O,
Higgins JPT, Langan D, Salanti G. Methods to estimate the between-study variance
and its uncertainty in meta-analysis. Research Synthesis Methods 2015; 7: 55–79.
11
[2] DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials
1986; 7: 177–188.
[3] Chung Y, Rabe-Hesketh S, Choi I-H. Avoiding zero between-study variance estimates
in random-effects meta-analysis. Statistics in Medicine 2013; 32: 4071–4089.
[4] Friede T, Ro¨ver C, Wandel S, Neuenschwander B. Meta-analysis of few small studies
in orphan diseases. Research Synthesis Methods 2017; 8: 79–91.
[5] Follmann DA, Proschan MA (1999). Valid inference in random effects meta-analysis.
Biometrics 1999; 55: 732–737.
[6] Hartung J, Knapp G. On tests of the overall treatment effect in meta-analysis with
normally distributed responses. Statistics in Medicine 2001; 20: 1771–1782.
[7] Hartung J, Knapp G. A refined method for the meta-analysis of controlled clinical
trials with binary outcome. Statistics in Medicine 2001; 20: 3875–3889.
[8] Sidik K, Jonkman JN. A simple confidence interval for meta-analysis. Statistics in
Medicine 2002; 21: 3153–3159.
[9] Ro¨ver C, Knapp G, Friede T. Hartung-Knapp-Sidik-Jonkman approach and its mod-
ification for random-effects meta-analysis with few studies. BMC Medical Research
Methodology 2015; 15: 99.
[10] Seide SE, Ro¨ver C, Friede T. Likelihood-based meta-analysis with few studies: Em-
pirical and simulation studies. BMC Medical Research Methodology 2019; 19: 16.
[11] Friede T, Ro¨ver C, Wandel S, Neuenschwander B. Meta-analysis of two studies in
the presence of heterogeneity with applications in rare diseases. Biometrical Journal
2017; 59: 658–671.
[12] Bender R, Friede T, Koch A, Kuß O, Schlattmann P, Schwarzer G, Skipka G. Methods
for evidence synthesis in the case of very few studies. Research Synthesis Methods
2018; 9: 382–392.
[13] Rosenthal R. The file drawer problem and tolerance for null results. Psychological
Bulletin 1979; 86: 638–641.
[14] Boutron I, Page MJ, Higgins JPT, Altman DG, Lundh A, Hrobjartsson A. Chapter 7:
Considering bias and conflicts of interest among the included studies. In: Higgins JPT,
Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane
Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019).
Cochrane, 2019. Available from www.training.cochrane.org/handbook.
[15] Jin ZC, Zhou XH, He J. Statistical methods for dealing with publication bias in
meta?analysis. Statistics in Medicine 2015; 34: 343–360.
[16] Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a
simple, graphical test. BMJ 1997; 315: 629–634.
[17] Duval S, Tweedie R. A nonparametric ”‘trim and fill”’ method of accounting for
publication bias in meta-analysis. Journal of the American Statistical Association
2000; 95: 89–98.
12
[18] Copas J, Shih JQ. Meta-analysis, funnel plots and sensitivity analysis. Biostatistics
2000; 1: 247–262.
[19] Copas J, Jackson D. A bound for publication bias based on the fraction of unpublished
studies. Biometrics 2004; 60: 146–153.
[20] Henmi M, Copas JB, Eguchi S. Confidence intervals and p-values for meta-analysis
with publication bias. Biometrics 2007; 63: 475–482.
[21] Crins ND, Ro¨ver C, Goralczyk AD, Friede T. Interleukin-2 receptor antagonists for
pediatric liver transplant recipients: a systematic review and meta-analysis of con-
trolled studies. Pediatric Transplantation 2014; 18: 839–850.
[22] Henmi M, Copas JB. Confidence intervals for random effects meta-analysis and ro-
bustness to publication bias. Statistics in Medicine 2010; 29: 2969–2983.
[23] Doi SAR, Barendregt JJ, Khan S, Thalib L, Williams GM. Advances in the meta-
analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model.
Contemporary Clinical Trials 2015; 45: 130–138.
[24] Veroniki AA, Jackson D, Bender R, Kuss O, Langan D, Higgins JPT, Knapp G,
Salanti G. Methods to calculate uncertainty in the estimated overall effect size from
a random-effects meta-analysis. Research Synthesis Methods 2019; 10: 23–43.
[25] Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and
Health-Care Evaluation. Chichester: Wiley; 2004.
[26] Gelman A. Prior distributions for variance parameters in hierarchical mod-
els(Comment on Article by Browne and Draper). Bayesian Analysis 2006; 1: 515–534.
[27] Brockwell SE, Gordon IR. A comparison of statistical methods for meta-analysis.
Statistics in Medicine 2001; 20: 825–840.
[28] Jackson D, Law M, Stijnen T, Viechtbauer W, White IR. A comparison of 7 random-
effects models for meta-analyses that estimate the summary odds ratio. Statistics in
Medicine 2018; 37: 1059–1085.
[29] Gu¨nhan BK, Ro¨ver C, Friede T. Meta-analysis of few studies involving rare events.
Research Synthesis Methods 2019; (in press).
[30] Gronsbell J, Hong C, Nie L, Lu Y, Tian L. Exact inference for the random-effect
model for meta-analyses with rare events. Statistics in Medicine 2019; (in press).
[31] Jackson D. The implications of publication bias for metaanalysis’ other parameter.
Statistics in Medicine 2006; 25: 2911–2921.
13
Table 2: Median lengths of the confidence intervals for various levels of publication bias
and heterogeneity τ2 as well as numbers of studies n included in the meta-analysis.
publication bias τ2 n DL HC HC-BM BM IVH
none 0.05 3 0.815 0.878 1.134 1.109 0.830
6 0.577 0.678 0.756 0.683 0.605
9 0.466 0.577 0.606 0.524 0.496
12 0.412 0.517 0.532 0.450 0.443
15 0.362 0.458 0.465 0.391 0.395
0.15 3 1.005 1.291 1.536 1.269 1.051
6 0.748 1.145 1.194 0.832 0.837
9 0.634 0.957 0.966 0.672 0.735
12 0.557 0.817 0.816 0.584 0.663
15 0.505 0.726 0.724 0.522 0.608
0.25 3 1.174 1.778 2.007 1.421 1.246
6 0.892 1.488 1.515 0.971 1.039
9 0.749 1.208 1.207 0.796 0.915
12 0.658 1.004 0.998 0.686 0.815
15 0.591 0.885 0.880 0.615 0.753
moderate 0.05 3 0.736 0.755 1.001 1.017 0.746
6 0.503 0.533 0.620 0.614 0.515
9 0.409 0.458 0.500 0.475 0.424
12 0.358 0.407 0.436 0.407 0.373
15 0.320 0.366 0.381 0.356 0.333
0.15 3 0.860 0.963 1.207 1.132 0.884
6 0.631 0.811 0.882 0.719 0.673
9 0.518 0.707 0.721 0.566 0.572
12 0.463 0.634 0.641 0.492 0.523
15 0.421 0.567 0.568 0.438 0.481
0.25 3 0.955 1.136 1.405 1.232 0.998
6 0.721 1.053 1.099 0.798 0.791
9 0.590 0.854 0.866 0.631 0.668
12 0.537 0.782 0.784 0.562 0.636
15 0.483 0.685 0.683 0.496 0.577
severe 0.05 3 0.691 0.729 0.942 0.963 0.704
6 0.477 0.510 0.598 0.587 0.489
9 0.385 0.416 0.461 0.446 0.395
12 0.334 0.371 0.394 0.379 0.345
15 0.303 0.343 0.358 0.336 0.315
0.15 3 0.827 0.916 1.162 1.083 0.849
6 0.584 0.757 0.814 0.681 0.619
9 0.495 0.674 0.691 0.540 0.541
12 0.443 0.602 0.607 0.466 0.496
15 0.403 0.539 0.542 0.421 0.456
0.25 3 0.920 1.110 1.363 1.161 0.958
6 0.683 0.988 1.031 0.759 0.744
9 0.577 0.841 0.850 0.609 0.657
12 0.509 0.726 0.728 0.528 0.595
15 0.459 0.643 0.643 0.474 0.543
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Table 3: Logarithm of the odds ratios (log OR) with standard errors (SE) for the endpoints
acute rejection (AR) and steroid-resistant rejection (SRR) as reported in the systematic
review by Crins et al [21].
AR SRR
Study log OR (SE) log OR (SE)
Heffron (2003) -2.31 (0.60) -2.00 (0.91)
Gibelli (2004) -0.46 (0.56)
Schuller (2005) -2.30 (0.88)
Ganschow (2005) -1.76 (0.46) -0.45 (0.68)
Spada (2006) -1.26 (0.64)
Gras (2008) -2.42 (1.53) -1.88 (1.14)
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